The insulin/IGF-1 (DAF-2) signaling pathway regulates innate immunity in C. elegans. We and others have previously shown that mutations in
daf-2 pathway genes and glp mutants enhance resistance to bacterial pathogens in a manner dependent on the FoxO transcription factor DAF-16 (1).Acetylation by CBP/p300, transcriptional cofactors with histone acetyltransferase activity, has been implicated as a regulator of FoxO activity in mammalian systems (2-5). These studies have suggested a model in which binding of CBP/p300 to FoxO factors is essential for FoxO-mediated transcription (6). Corroborating this model, we will present evidence that
cbp-1, the worm CPB/p300 homolog, is essential for the immunity enhancements mediated by DAF-16. RNAi of
cbp-1 at L4 suppresses resistance to Pseudomonas aeruginosa in the
rrf-3(
pk1426);
glp-4(
bn2) double mutant strain to the same extent as
daf-16 RNAi does.We also observe that continuous exposure of
daf-2(
e1370) mutant worms to the
cbp-1 RNAi feeding strain results in early death at a rate similar to
daf-16 RNAi. Assigning significance to this suppression with regard to the distinction between aging and immunity is not straightforward because live bacteria are used to induce RNAi. Although E. coli is often regarded as a non-pathogenic food for worms, there is evidence that bacterial proliferation is a cause of death in aging worms (7). We believe the confounding of aging and immunity within these assays is a problem that warrants further investigation.We are investigating the relationship between aging and immunity in the context of the DAF-2 pathway. We will present evidence for a model of distinct regulation of aging and immunity.(1) Garsin (2003) Science 300. (2) Brunet (2004) Science 303. (3) Motta (2004) Cell 116. (4) Daitoku (2004) PNAS 101. (5) van der Horst (2004) JBC 279. (6) van der Heide (2005) Trends Biochem Sci. 30. (7) Garigan (2002) Genetics 161.